Differences in Quality of Life After Thoracic Outlet Syndrome Surgery

December 8, 2022 updated by: University Hospital, Angers
Quality of life evaluation after thoracic outlet surgery with Quick-DASH and SF-36 forms

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • thoracic outel syndrome surgery scheduled in the vascular and thoracic surgery department of Angers ; age > 18 y ; french language understood

Exclusion Criteria:

  • denied of consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients with a completed form
Other: QuickDASH form
Patients have to complete these two forms, Quick DASH and SF-36, before surgery then 6 weeks after
Other Names:
  • SF-36 form

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change from QuickDASH form results before surgery at 6 weeks after surgery
Time Frame: Results before surgery and at 6 weeks after surgery are compared
Results before surgery and at 6 weeks after surgery are compared

Secondary Outcome Measures

Outcome Measure
Time Frame
Change from SF-36 form results before surgery at 6 weeks after surgery
Time Frame: Results before surgery and at 6 weeks after surgery are compared
Results before surgery and at 6 weeks after surgery are compared

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Angers

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2022

Primary Completion (Anticipated)

March 14, 2025

Study Completion (Anticipated)

August 17, 2026

Study Registration Dates

First Submitted

June 10, 2022

First Submitted That Met QC Criteria

June 21, 2022

First Posted (Actual)

June 22, 2022

Study Record Updates

Last Update Posted (Estimate)

December 12, 2022

Last Update Submitted That Met QC Criteria

December 8, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-A01379-34

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thoracic Outlet Syndrome

Clinical Trials on QuickDASH form

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe